Forsigtighed anbefales, når SonoVue gives til patienter med klinisk signifikant lungesygdom, inklusiv svær kronisk obstruktiv lungesygdom.
Caution is advised when SonoVue is administered to patients with clinically significant pulmonary disease, including severe chronic obstructive pulmonary disease.